<DOC>
	<DOCNO>NCT02932020</DOCNO>
	<brief_summary>In pilot study , investigator test efficacy AlloGen-LI , allograft derive amniotic fluid , injected epidural space level spinal stenosis anti-inflammatory treatment relieve back leg pain symptom patient spinal stenosis and/or disc herniation . The patient follow 12 week . The effect treatment examine patient report change pain disability utilizing validate outcome measure , MRI image evaluate change contrast enhancement T2 signal related reflect inflammation degeneration .</brief_summary>
	<brief_title>AlloGen-LI Treatment Spinal Stenosis</brief_title>
	<detailed_description>AlloGen-LI contains multiple factor may serve ameliorate detrimental effect osteorarthritis degenerative disc disease . Anti-inflammatory component include inhibitor matrix metalloproteins pro-inflammatory cytokine , growth factor interleukins . The product low immunogenicity hypo-osmotic.2 Placental tissue , include amniotic fluid , amniotic membrane chorion regulate human cell tissue product ( HCTP ) FDA . This regulation allow clinician use allograft material human injection . AlloGen-LI derive placental tissue obtain carefully screen healthy mother time schedule cesarean section . The mother agree donate tissue , would otherwise discard . The experimental treatment would entail injection one dose AlloGen-LI marcaine epidural space CT guidance , identical manner traditional epidural steroid /marcaine injection .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Low back pain &gt; 45 week &lt; 67 month 2 . Evidence least mild lumbar stenosis /disc herniation MRI 3 . Failure conservative therapy include physical therapy pharmacotherapy 4 . Patient least 18 year age 5 . Patient willing blind treatment 12 week post injection visit 6 . Patient willing able review sign study inform consent form 1 . No evidence lumbar stenosis disc herniation MRI 2 . Patient prior lumbar surgery level 3 . Patient receive epidural steroid injection past 6 month 4 . Patient currently receive systemic steroid another medical condition 5 . Patient pregnant 6 . Patient systemic infection propose injection site 7 . Patient systemic malignancy 8 . Current therapy immunosuppressive medication 9 . History solid organ hematologic transplantation 10 History autoimmune disorder 11 . Patient know allergy lidocaine , marcaine steroid 12 . Devices condition contraindication MRI examination ( routinely screen MRI examination ) . 13 . Patient anticoagulant medication ( ASA ) . 14 . Patient eGFR &lt; 40 15 . Patient know chronic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>disc herniation</keyword>
	<keyword>spinal stenosis</keyword>
</DOC>